Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders
- 22 April 2016
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 39 (5) , 661-672
Abstract
Background: Patients with urea cycle disorders (UCDs) have an increased risk of neurological disease manifestation.Aims: Determining the effect of diagnostic and therapeutic interventions on the neurological outcome.Methods: Evaluation of baseline, regular follow‐up and emergency visits of 456 UCD patients prospectively followed between 2011 and 2015 by the E‐IMD patient registry.Results: About two‐thirds of UCD patients remained asymptomatic until age 12 days [i.e. the median age at diagnosis of patients identified by newborn screening (NBS)] suggesting a potential benefit of NBS. In fact, NBS lowered the age at diagnosis in patients with late onset of symptoms (>28 days), and a trend towards improved long‐term neurological outcome was found for patients with argininosuccinate synthetase and lyase deficiency as well as argininemia identified by NBS. Three to 17 different drug combinations were used for maintenance therapy, but superiority of any single drug or specific drug combination above other combinations was not demonstrated. Importantly, non‐interventional variables of disease severity, such as age at disease onset and peak ammonium level of the initial hyperammonemic crisis (cut‐off level: 500 μmol/L) best predicted the neurological outcome.Conclusions: Promising results of NBS for late onset UCD patients are reported and should be re‐evaluated in a larger and more advanced age group. However, non‐interventional variables affect the neurological outcome of UCD patients. Available evidence‐based guideline recommendations are currently heterogeneously implemented into practice, leading to a high variability of drug combinations that hamper our understanding of optimised long‐term and emergency treatment.Keywords
Funding Information
- European Parliament (EAHC No 2010 12 01)
- Kindness for Kids Foundation
- Dietmar Hopp Stiftung
- radiz
- Association "La vita e un dono"
This publication has 42 references indexed in Scilit:
- The incidence of urea cycle disordersMolecular Genetics and Metabolism, 2013
- Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2 – From screening laboratory results to treatment, follow‐up and quality assuranceJournal of Inherited Metabolic Disease, 2012
- Suggested guidelines for the diagnosis and management of urea cycle disordersOrphanet Journal of Rare Diseases, 2012
- Long‐term outcome and intervention of urea cycle disorders in JapanJournal of Inherited Metabolic Disease, 2011
- Diagnosis and management of glutaric aciduria type I – revised recommendationsJournal of Inherited Metabolic Disease, 2011
- Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21‐year, multicentre study of acute hyperammonaemic episodesActa Paediatrica, 2008
- Unbiased Recursive Partitioning: A Conditional Inference FrameworkJournal of Computational and Graphical Statistics, 2006
- Urea cycle defects: Management and outcomeJournal of Inherited Metabolic Disease, 2005
- Long-term outcome of patients with urea cycle disorders and the question of neonatal screeningEuropean Journal of Pediatrics, 2003
- Neurologic Outcome in Children with Inborn Errors of Urea SynthesisNew England Journal of Medicine, 1984